Cytomx Therapeutics, Inc.

Bryan Allen Irving

Sherry Lynn La Porte

Daniel Robert Hostetter

Leila Marie Boustany

Jeanne Grace Flandez

Jason Gary Sagert

Olivia Jennifer Razo

Jennifer Hope Richardson

Clayton William White

Henry Bernard Lowman

James William West

Chihunt Wong

Chihong Wong

Provided herein antibodies, activatable antibodies (AAs), bispecific antibodies, and bispecific activatable antibodies (BAAs). Also provided herein are methods of making and methods of use of these antibodies, AAs, bispecific antibodies, and BAAs.

Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof

The invention relates generally to antibodies, activatable antibodies, multispecific antibodies, and multispecific activatable antibodies that specifically bind to at least CD3, as well as to methods of making and using these antibodies, activatable antibodies, multispecific antibodies, and/or multispecific activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.

Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same

The invention relates generally to multispecific antibodies and to multispecific activatable antibodies that specifically bind to two or more different antigens or epitopes, as well as to methods of making and using these multispecific antibodies and/or multispecific activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.

Multispecific antibodies, multispecific activatable antibodies and methods of using the same

Growing community of inventors

Woodside, CA, United States of America

Bryan Allen Irving